An in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.
Features and Benefits
Technical Specifications
Features and Benefits
- Includes positive and negative control swabs
- Innovative flip design with onboard sample extraction
- Pre-measured developer solution capsule for increased accuracy and ease of use
- Available results in 10 minutes .
- Flocked nasal swab for improved patient comfort and superior specimen collection
- CLIA waived for nasal swab and nasopharyngeal swab samples
Technical Specifications
- Influenza A:
- Positive % Agreement: 89.2%
- Negative % Agreement: 99.4%
- Influenza B:
- Positive % Agreement: 86.4%
- Negative % Agreement: 99.0%
- CPT Code 87084QW: Influenza A; National Average - $15.39
- CPT Code 87084QW-59: Influenza B; National Average - $15.39
